Gene Regulation Mechanisms by the APP/Fe65/TIP60 Complex

APP/Fe65/TIP60 复合物的基因调控机制

基本信息

  • 批准号:
    6887390
  • 负责人:
  • 金额:
    $ 29.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term objective is to elucidate the molecular mechanisms of transcriptional regulation of human gene expression in response to Amyloid Precursor Protein (APP) signaling. APP is a transmembrane protein that is the precursor of the beta-amyloid peptide (Abeta), the major component of amyloid plaques that characterize Alzheimer's disease. This peptide is generated from APP through proteolysis by the beta- and gamma-secretases. Following proteolysis, the released 47-residue cytoplasmic domain of APP (APP-C) interacts with the proteins Fe65 and TIP60, forming a nuclear complex that regulates gene expression. However, despite the central importance of the APP-C in human physiology and Alzheimer's disease pathogenesis, the sequence-specific DNA-binding transcription factors that recruit the TIP60/Fe65/APP-C complex onto the promoters of human genes and the molecular mechanisms underlying the transcriptional regulation by this complex remain elusive. TIP60 has histone acetyltransferase (HAT) activity with unique substrate specificity and interacts with class I nuclear receptors, supporting the hypothesis that these transcription factors may mediate APP-C signaling in the nucleus. This proposal will test this hypothesis and will focus on a mechanistic analysis of the APP-C signaling in gene regulation. The Specific Aims are: 1) To dissect the molecular mechanisms of gene regulation by the TIP60/Fe65/APP-C complex through its association with the androgen and estrogen receptors, using protein-protein interaction assays, in combination with site-directed mutagenesis and transient transfection experiments. 2) To elucidate the structural basis of the TIP60 HAT substrate specificity and the structural determinants of the TIP60 interaction with the androgen and estrogen receptors. 3) To determine the three-dimensional conformational changes induced on the TIP60/Fe65 complex by the APP-C binding, using X-ray crystallography. These studies will provide high-resolution three-dimensional structures of the TIP60, Fe65, and APP-C proteins, and will provide mechanistic insights into the regulation of human gene expression in response to APP signaling. This information could be used for the development of novel strategies in the treatment of Alzheimer's disease.
描述(由申请人提供):我们的长期目标是阐明淀粉样前体蛋白(APP)信号响应中人类基因表达转录调控的分子机制。APP是一种跨膜蛋白,是β -淀粉样肽(Abeta)的前体,是阿尔茨海默病淀粉样斑块的主要成分。这种肽是由APP通过分泌酶和分泌酶的蛋白水解而产生的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN A.A. LADIAS其他文献

JOHN A.A. LADIAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN A.A. LADIAS', 18)}}的其他基金

Structural Basis for Cannabinoid Receptor 2 Signaling
大麻素受体 2 信号传导的结构基础
  • 批准号:
    8010759
  • 财政年份:
    2010
  • 资助金额:
    $ 29.75万
  • 项目类别:
Structural Basis for Cannabinoid Receptor 2 Signaling
大麻素受体 2 信号传导的结构基础
  • 批准号:
    8109386
  • 财政年份:
    2010
  • 资助金额:
    $ 29.75万
  • 项目类别:
Gene Regulation Mechanisms by the APP/Fe65/TIP60 Complex
APP/Fe65/TIP60 复合物的基因调控机制
  • 批准号:
    7054772
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Gene Regulation Mechanisms by the APP/Fe65/TIP60 Complex
APP/Fe65/TIP60 复合物的基因调控机制
  • 批准号:
    7221165
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Molecular Mechanisms of CFTR Regulation
CFTR调控的分子机制
  • 批准号:
    7035846
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Gene Regulation Mechanisms by the APP/Fe65/TIP60 Complex
APP/Fe65/TIP60 复合物的基因调控机制
  • 批准号:
    6598733
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Molecular Mechanisms of CFTR Regulation
CFTR调控的分子机制
  • 批准号:
    6630262
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Molecular Mechanisms of CFTR Regulation
CFTR调控的分子机制
  • 批准号:
    6875230
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Gene Regulation Mechanisms by the APP/Fe65/TIP60 Complex
APP/Fe65/TIP60 复合物的基因调控机制
  • 批准号:
    6743979
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:
Molecular Mechanisms of CFTR Regulation
CFTR调控的分子机制
  • 批准号:
    6731046
  • 财政年份:
    2003
  • 资助金额:
    $ 29.75万
  • 项目类别:

相似海外基金

The transcriptional control of vascular calcification in disease
疾病中血管钙化的转录控制
  • 批准号:
    10647475
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
  • 批准号:
    10844023
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity
饮食诱导肥胖中 ALCAT1 激活 NLRP3 的细胞机制
  • 批准号:
    10658507
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Redefining the factors that determine tear film stability to develop novel therapeutics for evaporative dry eye disease
重新定义决定泪膜稳定性的因素,开发蒸发性干眼病的新疗法
  • 批准号:
    10678045
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Recombinant production of structured fats that mimic human milk fat
重组生产模仿人乳脂肪的结构脂肪
  • 批准号:
    10822765
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Triggering a New Cancer Cell Death Mechanism in Sarcoma
触发肉瘤中新的癌细胞死亡机制
  • 批准号:
    10735740
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
The Function of Mammalian LPGAT1
哺乳动物LPGAT1的功能
  • 批准号:
    10563280
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Enzymology of Bacteroides short and branched chain fatty acid metabolism
拟杆菌短链和支链脂肪酸代谢的酶学
  • 批准号:
    10651505
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 29.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了